medullary thyroid cancer and glp-1 Receptor Agonists Risk, Rodent Data and FDA Warning, • In rodents, GLP-1 receptor agonists (GLP-1 RAs) stimulate thyroid C-cells, increasing the incidence of thyroid GLP-1 analogues do not increase

Genetic therapy approaches for ornithine transcarbamylase deficiency

[DOI] [PMC free article] [PubMed] [Google Scholar] 25.Acosta A, Camilleri M, Burton D, et al

In OVX rats, HEXA did not modify the OVX-induced increase in bone turnover markers (Dpd and ALP) and did not affect the OVX-induced vertebral bone loss, but significantly increased BMC (+7.2%) and bone area (+5.3%) at femoral mid-diaphyses

They can also monitor for, and advise on, severe adverse events like gallbladder issues or pancreatitis, and order and interpret baseline and follow-up lab work

The variant that causes chronic hemolysis is uncommon because it is related to sporadic gene mutation rather than the more common inherited gene mutation

Fan R, Xu L, Cui B et al (2023) Genomic characterization revealed PM2.5-associated mutational signatures in lung cancer including activation of APOBEC3B